Are you a tattoo person? Maybe you have a lot of body art already but had to take an ink hiatus w...
... Has your medical oncology team talked to you about how long you’ll be on it? Share your experience in the comments below, or start a conversation by posting on your Activities page. ...
Dreading your next mammogram? You’re not alone. The physical pain from this important screening i...
... Sacituzumab govitecan-hziy contains a monoclonal antibody that targets and binds to a protein called trophoblast cell-surface antigen 2 (TROP2) on cancer cells. It then delivers a drug into the cell that causes its death. ...
... Your oncologist may have to balance some unwanted treatment effects (known as toxicity) to help you live as long as possible. ...
... Burst Edition: FDA Approval of Trodelvy (Sacituzumab Govitecan-Hziy) for HR-Positive Breast Cancer — U.S. ...
... More information on long-term side effects may emerge as ongoing clinical trials are completed.Talk With Others Who UnderstandOn MyBCTeam, people share their experiences with breast cancer, get advice, and find support from others who understand.Have you taken a targeted drug therapy for breast cancer? Let others know in comments below. ...
Targeted Therapy for Breast Cancer: Types, Side Effects, and More
... More information on long-term side effects may emerge as ongoing clinical trials are completed.Talk With Others Who UnderstandOn MyBCTeam, people share their experiences with breast cancer, get advice, and find support from others who understand.Have you taken a targeted drug therapy for breast cancer? Let others know in comments below. ...
... Meaningful Improvement in Progression Free Survival in Patients With First-Line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors — Gilead Sciences Gilead Records Another Pivotal Study Success for Trodelvy in First-Line TNBC — FirstWord Pharma Highlights of Prescribing Information: Trodelvy (Sacituzumab Govitecan-Hziy ...
Trodelvy Extends TNBC Life Expectancy in Phase 3 Trials
... Meaningful Improvement in Progression Free Survival in Patients With First-Line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors — Gilead Sciences Gilead Records Another Pivotal Study Success for Trodelvy in First-Line TNBC — FirstWord Pharma Highlights of Prescribing Information: Trodelvy (Sacituzumab Govitecan-Hziy ...
... The side effects you may experience while taking chemotherapy for TNBC can change depending on the drugs you receive, the dose, and how long you’re treated.Common chemotherapy side effects you may experience include: Hair loss Fatigue Nausea, vomiting, and loss of appetite Weight loss Mouth sores Diarrhea Chemotherapy can also trigger early menopause ...
Chemotherapy for Triple-Negative Breast Cancer: 5 Facts To Know
... The side effects you may experience while taking chemotherapy for TNBC can change depending on the drugs you receive, the dose, and how long you’re treated.Common chemotherapy side effects you may experience include: Hair loss Fatigue Nausea, vomiting, and loss of appetite Weight loss Mouth sores Diarrhea Chemotherapy can also trigger early menopause ...
... References Triple-Negative Breast Cancer — American Cancer Society Risk of Regional Recurrence in Triple-Negative Breast Cancer Patients: A Dutch Cohort Study — Breast Cancer Research and Treatment Triple-Negative Breast Cancer: Current Treatment Strategies and Factors of Negative Prognosis — Journal of Medicine and Life Long-Term Survival Outcomes ...
Triple-Negative Breast Cancer Recurrence Rate: 8 Facts To Know
... References Triple-Negative Breast Cancer — American Cancer Society Risk of Regional Recurrence in Triple-Negative Breast Cancer Patients: A Dutch Cohort Study — Breast Cancer Research and Treatment Triple-Negative Breast Cancer: Current Treatment Strategies and Factors of Negative Prognosis — Journal of Medicine and Life Long-Term Survival Outcomes ...
Join
